Cargando…

Antioxidant Therapies for Alzheimer's Disease

Alzheimer's disease (AD) is the most common neurodegenerative disease featuring progressive impairments in memory, cognition, and behavior and ultimately leads to death. The histopathological changes of Alzheimer's disease include neuronal and synaptic loss, formation of extracellular seni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Ye, Wang, Xiaochuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410354/ https://www.ncbi.nlm.nih.gov/pubmed/22888398 http://dx.doi.org/10.1155/2012/472932

Ejemplares similares

Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease
por: Collins, Andrila E., et al.
Publicado: (2022)

Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
por: Varesi, Angelica, et al.
Publicado: (2023)

Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail?
por: Persson, Torbjörn, et al.
Publicado: (2014)

Alzheimer’s Disease, Inflammation, and the Role of Antioxidants
por: Sinyor, Benjamin, et al.
Publicado: (2020)

Alzheimer’s Disease: From Pathogenesis to Mesenchymal Stem Cell Therapy – Bridging the Missing Link
por: Hu, Jingqiong, et al.
Publicado: (2022)

Defective mitophagy and the etiopathogenesis of Alzheimer’s disease
por: Zeng, Kuan, et al.
Publicado: (2022)

Involvement of calpain in the neuropathogenesis of Alzheimer’s disease
por: Mahaman, Yacoubou Abdoul Razak, et al.
Publicado: (2018)

Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease
por: Jové, Mariona, et al.
Publicado: (2023)

Tau Ubiquitination in Alzheimer's Disease
por: Li, Longfei, et al.
Publicado: (2022)

Role of antioxidants and a nutrient rich diet in Alzheimer's disease
por: Veurink, Gerald, et al.
Publicado: (2020)

Prevention of Cognitive Decline in Alzheimer’s Disease by Novel Antioxidative Supplements
por: Tadokoro, Koh, et al.
Publicado: (2020)

Antioxidants in Alzheimer’s Disease: Current Therapeutic Significance and Future Prospects
por: Pritam, Pingal, et al.
Publicado: (2022)

The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment
por: Knight, Emily, et al.
Publicado: (2023)

Oxidant/Antioxidant Imbalance in Alzheimer's Disease: Therapeutic and Diagnostic Prospects
por: Wojsiat, Joanna, et al.
Publicado: (2018)

Alzheimer’s disease hypothesis and related therapies
por: Du, Xiaoguang, et al.
Publicado: (2018)

Antioxidant Compounds in the Treatment of Alzheimer's Disease: Natural, Hybrid, and Synthetic Products
por: Hatami, Maryam, et al.
Publicado: (2023)

Memantine Attenuates Alzheimer’s Disease-Like Pathology and Cognitive Impairment
por: Wang, Xiaochuan, et al.
Publicado: (2015)

Targeting HDACs: A Promising Therapy for Alzheimer's Disease
por: Xu, Ke, et al.
Publicado: (2011)

Potential Roles of Sestrin2 in Alzheimer’s Disease: Antioxidation, Autophagy Promotion, and Beyond
por: Chen, Shang-Der, et al.
Publicado: (2021)

Iron and Targeted Iron Therapy in Alzheimer’s Disease
por: Wang, Jian, et al.
Publicado: (2023)

Melatonin Therapy in Patients with Alzheimer’s Disease
por: Cardinali, Daniel P., et al.
Publicado: (2014)

The Rationale for Insulin Therapy in Alzheimer’s Disease
por: Ribarič, Samo
Publicado: (2016)

Stem cell therapy for Alzheimer's disease
por: Liu, Xin-Yu, et al.
Publicado: (2020)

The Development of Pharmacological Therapies for Alzheimer’s Disease
por: Lin, Ping, et al.
Publicado: (2021)

Antioxidant Therapy in Inflammatory Bowel Diseases
por: Dziąbowska-Grabias, Katarzyna, et al.
Publicado: (2021)

Imidazopyranotacrines as Non-Hepatotoxic, Selective Acetylcholinesterase Inhibitors, and Antioxidant Agents for Alzheimer′s Disease Therapy
por: Boulebd, Houssem, et al.
Publicado: (2016)

Oxidative Stress and Aging as Risk Factors for Alzheimer’s Disease and Parkinson’s Disease: The Role of the Antioxidant Melatonin
por: Tchekalarova, Jana, et al.
Publicado: (2023)

Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
por: Abdel Moneim, Ahmed E.
Publicado: (2015)

The Roles of Biomarkers of Oxidative Stress and Antioxidant in Alzheimer's Disease: A Systematic Review
por: Chang, Ya-Ting, et al.
Publicado: (2014)

Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
por: Quan, Meina, et al.
Publicado: (2023)

Alzheimer's Disease and Stem Cell Therapy
por: Choi, Sung S., et al.
Publicado: (2014)

Therapies for Prevention and Treatment of Alzheimer's Disease
por: Mendiola-Precoma, J., et al.
Publicado: (2016)

Cell Therapy Products in Alzheimer Disease
por: Song, Hyeon Jin, et al.
Publicado: (2017)

Alzheimer's and Parkinson's disease therapies in the clinic
por: Chopade, Puja, et al.
Publicado: (2022)

Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
por: Zhang, Chun-Ye, et al.
Publicado: (2023)

Effects of Resveratrol on the Mechanisms of Antioxidants and Estrogen in Alzheimer's Disease
por: Kong, Danli, et al.
Publicado: (2019)

Natural Compounds as Beneficial Antioxidant Agents in Neurodegenerative Disorders: A Focus on Alzheimer’s Disease
por: Amato, Antonella, et al.
Publicado: (2019)

Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010)

Pharmacological Basis for the Use of Evodiamine in Alzheimer’s Disease: Antioxidation and Antiapoptosis
por: Zhang, Yongfeng, et al.
Publicado: (2018)

Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
por: Zotova, Elina, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ft1ti14msdbbi5g4bmsvuq52j7